101 related articles for article (PubMed ID: 15057517)
1. Platelet monoamine oxidase activity in subjects tested for Huntington's disease gene mutation.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
J Neural Transm (Vienna); 2004 Apr; 111(4):475-83. PubMed ID: 15057517
[TBL] [Abstract][Full Text] [Related]
2. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase activity in Huntington's chorea.
Mann J; Chiu E
J Neurol Neurosurg Psychiatry; 1978 Sep; 41(9):809-12. PubMed ID: 151126
[TBL] [Abstract][Full Text] [Related]
4. Platelet monoamine oxidase activity in patients with Huntington's disease.
Norman TR; Chiu E; French MA
Clin Exp Pharmacol Physiol; 1987 Jun; 14(6):547-50. PubMed ID: 2960476
[TBL] [Abstract][Full Text] [Related]
5. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
6. Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication, and disease.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Szombathy T; Tekes K; Magyar K
Neurochem Res; 1998 Jun; 23(6):863-8. PubMed ID: 9572675
[TBL] [Abstract][Full Text] [Related]
7. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia].
Smirnov AV; Prilipko LL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255
[TBL] [Abstract][Full Text] [Related]
8. [Heterogeneity of platelet monoamine oxidase in man].
Moskvitina TA
Biull Eksp Biol Med; 1990 Feb; 109(2):152-3. PubMed ID: 2337649
[TBL] [Abstract][Full Text] [Related]
9. Platelet enzyme abnormalities in neuropsychiatric disease.
Farmer PM
Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
[TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase as a function of nongenetic factors.
Friedhoff AJ; Miller JC
Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
[TBL] [Abstract][Full Text] [Related]
12. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
Schneider G; Oepen H; von Wedel HR
Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
[TBL] [Abstract][Full Text] [Related]
13. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men.
Pivac N; Knezevic J; Mustapic M; Dezeljin M; Muck-Seler D; Kozaric-Kovacic D; Balija M; Matijevic T; Pavelic J
Life Sci; 2006 May; 79(1):45-9. PubMed ID: 16427095
[TBL] [Abstract][Full Text] [Related]
14. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
15. Platelet MAO activity in patients with affective psychosis and their first-degree relatives.
Maubach M; Diebold K; Friedl W; Propping P
Pharmacopsychiatria; 1981 May; 14(3):87-93. PubMed ID: 7255541
[TBL] [Abstract][Full Text] [Related]
16. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.
Richards G; Messer J; Waldvogel HJ; Gibbons HM; Dragunow M; Faull RL; Saura J
Brain Res; 2011 Jan; 1370():204-14. PubMed ID: 21075085
[TBL] [Abstract][Full Text] [Related]
18. Platelet MAO concentration and molecular activity: I. New methods using an MAO B-specific monoclonal antibody in a radioimmunoassay.
Fritz RR; Abell CW; Denney RM; Denney CB; Bessman JD; Boeringa JA; Castellani S; Lankford DA; Malek-Ahmadi P; Rose RM
Psychiatry Res; 1986 Feb; 17(2):129-40. PubMed ID: 3961030
[TBL] [Abstract][Full Text] [Related]
19. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
[TBL] [Abstract][Full Text] [Related]
20. Blood monoamine metabolism in Huntington's disease.
Belendiuk K; Belendiuk GW; Freedman DX
Arch Gen Psychiatry; 1980 Mar; 37(3):325-32. PubMed ID: 6102459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
